TCG Lifesciences Limited
TCG Lifesciences Limited (formerly Chembiotek) is a leading contract research organization in early drug discovery and development. We are a part of ‘The Chatterjee Group’ (TCG), a global investment conglomerate headquartered in New York with strategic investments of over USD 1 Billion. The group is established by Dr. Purnendu Chatterjee. TCG is internationally known for generating significant capital appreciation through long term strategic investments, both in the private and public sectors.
We started our operations in 2001 in India. Currently we have our presence in United States, Europe, Japan and Australia. We have a strong talent pool of 800+ qualified and trained scientists, drawn from the best national and international institutes and industry.
Spread over 250,000 sq. ft. of space our services span from specific solutions to integrated discovery projects across multiple therapeutic areas with focus on Central Nervous System (CNS), Inflammation & Pain, Metabolic Disorders and Infectious Diseases. Our research infrastructure includes world class chemistry and biology laboratories, animal facility, and cGMP scale-up facilities at our R&D centers in Kolkata and Pune, India.
We partner with global pharma and biotechnology companies and collaboratively discover new molecules to address unmet medical needs. Collaborating with bio-medical researchers, research institutions and academia we accelerate generation of knowledge and leverage innovation and technology platforms.